No Patent Rights or other intellectual property rights licensed to Acceleron under either (a) that certain Exclusive License Agreement dated August 10, 2010 between Acceleron and the Salk Institute for Biological Studies or (b) that certain Exclusive License Agreement dated August 11, 2010 between Acceleron and the Salk Institute for Biological Studies relate to or are necessary or useful to Develop, Manufacture or Commercialize a Licensed Compound or a Licensed Product in the Field. Celgene shall not have any obligations under (including any financial obligations), or be subject to any restrictions set forth in, either such agreement with Salk Institute for Biological Studies.
No Patent Rights. The Company does not own, hold, or have any right, license or immunity with respect to any patents, inventions, industrial models, processes, designs, formulas or applications for patents. To the Seller's Knowledge, the Company has not infringed, nor is the Company now infringing, on any patent or other right belonging to any Person. Except as disclosed on Schedule 1.2, the Company is not a party to any license, agreement or arrangement, whether as licensee, licensor or otherwise, with respect to any patent, application for patent, invention, design, model, process, trade secret or formula.
No Patent Rights. Except as described in SCHEDULE 6.16, Seller neither owns, holds, nor has any rights, licenses or immunities with respect to any patents, inventions, industrial models, processes, designs, formulas and applications for patents. Seller has not infringed and is not now infringing on any patent or other right belonging to any person, firm, or corporation. Except as described in SCHEDULE 6.16, Seller is not a party to any license, agreement, or arrangement, whether as licensee, licensor, or otherwise, with respect to any patent, application for patent, invention, design, model, process, trade secret, or formula.
No Patent Rights. 18 3.5 Free Passes.............................................................................. 18 3.6 Contracts................................................................................ 18 3.7
No Patent Rights or other intellectual property rights licensed to Acceleron under either (a) that certain Exclusive License Agreement dated August 10, 2010 between Acceleron and the Salk Institute for Biological Studies or (b) that certain Exclusive License Agreement dated August 11, 2010 between Acceleron and the Salk Institute for Biological Studies relate to or are necessary or useful to Develop, Manufacture or Commercialize a Licensed Compound or a Licensed Product in the Field. Celgene shall not have any obligations under (including any financial obligations), or be subject to any restrictions set forth in, either such agreement with Salk Institute for Biological Studies. 11.2.3. To the best knowledge of Acceleron and its Affiliates, there is no actual or threatened infringement of the Acceleron Patent Rights in the Field by any Third Party or any other infringement or threatened infringement that would adversely affect Celgene’s rights under this Agreement. 11.2.4. There are no claims, judgments or settlements against or owed by Acceleron or its Affiliates or pending or, to the best knowledge of Acceleron and its Affiliates, threatened claims or litigation relating to the Acceleron Technology that would impact activities under this Agreement. 76 THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST. REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. 11.2.5. The Third Party Licenses, as provided to Celgene, are each in full force and effect and none has been modified or amended. 11.2.6. Neither Acceleron nor, to the best knowledge of Acceleron, any Third Party Licensor is in default with respect to a material obligation under, and neither such party has claimed or has grounds upon which to claim that the other party is in default with respect to a material obligation under, any Third Party License. 11.2.7. There are no Third Party Patent Rights. There are no Patent Rights or Know-How Controlled by Acceleron through a license from a Third Party that are necessary or useful to Develop, Manufacture or Commercialize a Licensed Compound or a Licensed Product in the Field, including no Patent Rights or Know-How licensed to Acceleron pursuant to the agreements set forth on Schedule 11.2.13(a) that are necessary or useful to Develop, Manufacture or Commercialize a Licensed Compound or a Licensed Product in the Field. 11.2.8. Acceleron has not waived or allowed to lapse any of its...
No Patent Rights. 11 3.5 Passes . . . . . . . . . . . . . . . . . . . 11 3.6 Contracts. . . . . . . . . . . . . . . . . . 11 3.7
No Patent Rights. Nothing in this Agreement shall be construed as an obligation on Sellers or Affiliates of Sellers to obtain or maintain patent rights. Notwithstanding the foregoing or any other terms of this Agreement, Purchaser shall be solely responsible for obtaining any consents, assignments of rights or licenses with respect to any third party patents, copyrights, trademarks, trade secrets, technology or other Intellectual Property (including process and software licenses) used in the operation of the Assets.
No Patent Rights. Except as identified on Schedule 1.1, the Company does not own, hold, or have any right, license or immunity with respect to any patents or applications for patents. To the Company's Knowledge, it has not infringed, nor is it now infringing, on any patent or other right belonging to any Person. The Company is not a party to any license, agreement or arrangement, whether as licensee, licensor or otherwise, with respect to any patent or application for any patent.
No Patent Rights. The Corporation does not own, hold or have any rights, licenses or immunities with respect to any patents, inventions, industrial models, processes, designs, formulas and applications for patents. The Corporation has not infringed and is not now infringing on any patent or related right belonging to any person, firm, or corporation. The Corporation is not a party to any license, agreement, or arrangement, whether as licensee, licensor, or otherwise, with respect to any patent, application for patent, invention, design, model, process, trade secret, or formula.
No Patent Rights. 16 3.5 Ski and Other Passes.........................................16 3.
